How much is the Biosurgery Market?

USD 29,692.5 Million (2035) Read More

Who are the key players in the Biosurgery Market?

Integra Lifesciences Holdings Corporation, Johnson & Johnson Inc., Sanofi, Baxter, Zimmer Biomet Becton, Dickinson and Company, Medtronic, Stryker, Smith + Nephew. Read More

Which End Use had the largest market share in the Biosurgery Market?

hospitals and clinics Read More

Biosurgery Market

ID: MRFR/MED/4785-CR

200 Pages

Rahul Gotadki

Last Updated: March 27, 2026

Biosurgery Market Research Report Information by Product Type (Bone-graft substitutes, Hemostatic agents, Soft-tissue attachments, Surgical sealants and adhesives, Adhesion barriers), By Application (Neurological surgery, general surgery, cardiovascular surgery, orthopedic surgery, thoracic surgery, gynecology surgery, urology surgery, and other), By End Use (hospitals and clinics, ambulatory surgical centers, and others), By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) - Forecast to 2035

Summary Table of Contents Segmentation Methodology Download PDF

1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
1. 2.1 DEFINITION
2. 2.2 SCOPE OF THE STUDY
3. 2.3 RESEARCH OBJECTIVE
4. 2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
1. 3.1 OVERVIEW
2. 3.2 DATA FLOW
  1. 3.2.1 Data Mining Process
3. 3.3 PURCHASED DATABASE:
4. 3.4 SECONDARY SOURCES:
  1. 3.4.1 Secondary Research data flow:
5. 3.5 PRIMARY RESEARCH:
  1. 3.5.1 Primary Research Data Flow:
  2. 3.5.2 Primary Research: Number of Interviews conducted
  3. 3.5.3 Primary Research: Regional Coverage
6. 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
  1. 3.6.1 Revenue Analysis Approach
7. 3.7 DATA FORECASTING
  1. 3.7.1 Data forecasting Type
8. 3.8 DATA MODELING
  1. 3.8.1 microeconomic factor analysis:
  2. 3.8.2 Data modeling:
9. 3.9 TEAMS AND ANALYST CONTRIBUTION
4 MARKET DYNAMICS
1. 4.1 INTRODUCTION
2. 4.2 DRIVERS
  1. 4.2.1 Increasing Prevalence of Chronic Diseases
  2. 4.2.2 Advancements in surgical techniques and technologies
  3. 4.2.3 Expanding aging population prone to chronic diseases leading to higher surgical interventions
3. 4.3 RESTRAINTS
  1. 4.3.1 High Cost of Biosurgical Products
  2. 4.3.2 Regulatory Challenges and Approval Delays
  3. 4.3.3 Limited awareness/training among healthcare professionals
4. 4.4 OPPORTUNITIES
  1. 4.4.1 Expansion into emerging markets
  2. 4.4.2 Integration of artificial intelligence and machine learning in biosurgery
5 INDUSTRY TREND ANALYSIS
1. 5.1 REGULATORY ENVIRONMENT & COMPLIANCE
  1. 5.1.1 Analysis of Regulatory Environment
  2. 5.1.2 Impact of Upcoming Regulations and Standards
2. 5.2 TECHNOLOGICAL TRENDS & INNOVATION
3. 5.3 PATIENT DEMOGRAPHICS & DISEASE BURDENS
4. 5.4 PRICING ANALYSIS & REIMBURSEMENT DYNAMICS
  1. 5.4.1 Pricing Analysis
  2. 5.4.2 Reimbursement Rates and Policies
5. 5.5 MARKET ENTRY & EXIT BARRIERS
6. 5.6 PARTNERSHIPS & COLLABORATIONS
  1. 5.6.1 Strategic Alliances, Joint Ventures, Licensing Deals
  2. 5.6.2 Academic Collaborations and Clinical Trials
  3. 5.6.3 Contract Manufacturing Relationships
7. 5.7 CONSUMER & HEALTHCARE PROVIDER PREFERENCES
8. 5.8 PESTLE ANALYSIS
9. 5.9 PORTER'S FIVE FORCES MODEL
  1. 5.9.1 Bargaining Power of Suppliers
  2. 5.9.2 Bargaining Power of Buyers
  3. 5.9.3 Threat of New Entrants
  4. 5.9.4 Threat of Substitutes
  5. 5.9.5 Intensity of Rivalry
10. 5.10 PRODUCT PIPELINE ANALYSIS
11. 5.11 CASE STUDY ANALYSIS
12. 5.12 INVESTMENT & FUNDING SCENARIOS
13. 5.13 POST-MARKET SURVEILLANCE & SAFETY DATA
  1. 5.13.1 Recall Histories
  2. 5.13.2 Quality Assurance and Compliance Metrics
6 GLOBAL BIOSURGERY MARKET, BY PRODUCT TYPE
1. 6.1 OVERVIEW
  1. 6.1.1 Bone-graft substitutes
  2. 6.1.2 Hemostatic agents
  3. 6.1.3 Soft-tissue attachments
  4. 6.1.4 Surgical sealants and adhesives
  5. 6.1.5 Adhesion barriers
7 GLOBAL BIOSURGERY MARKET, BY APPLICATION
1. 7.1 OVERVIEW
8 GLOBAL BIOSURGERY MARKET, BY END USE
1. 8.1 OVERVIEW
9 GLOBAL BIOSURGERY MARKET, BY REGION
1. 9.1 OVERVIEW
2. 9.2 NORTH AMERICA
  1. 9.2.1 US
  2. 9.2.2 Canada
3. 9.3 EUROPE
  1. 9.3.1 Germany
  2. 9.3.2 UK
  3. 9.3.3 France
  4. 9.3.4 Russia
  5. 9.3.5 Italy
  6. 9.3.6 Spain
  7. 9.3.7 Rest of EuropE
4. 9.4 ASIA-PACIFIC
  1. 9.4.1 China
  2. 9.4.2 India
  3. 9.4.3 Japan
  4. 9.4.4 South Korea
  5. 9.4.5 Malaysia
  6. 9.4.6 Thailand
  7. 9.4.7 Indonesia
  8. 9.4.8 Rest of Asia-Pacific
5. 9.5 LATIN AMERICA
  1. 9.5.1 Brazil
  2. 9.5.2 Mexico
  3. 9.5.3 Argentina
  4. 9.5.4 Rest of Latin America
6. 9.6 MIDDLE EAST & AFRICA
  1. 9.6.1 gcc countries
  2. 9.6.2 south africa
  3. 9.6.3 Rest of MEA
10 COMPETITIVE LANDSCAPE
1. 10.1 INTRODUCTION
2. 10.2 MARKET SHARE ANALYSIS, 2024
3. 10.3 COMPETITOR DASHBOARD
4. 10.4 PUBLIC PLAYERS STOCK SUMMARY
5. 10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL
6. 10.1 KEY DEVELOPMENTS & GROWTH STRATEGIES
  1. 10.1.1 Product Launch
  2. 10.1.2 Product Development
  3. 10.1.3 Partnership
  4. 10.1.4 Acquisition/ Expansion
11 COMPANY PROFILES
1. 11.1 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  1. 11.1.1 COMPANY OVERVIEW
  2. 11.1.2 FINANCIAL OVERVIEW
  3. 11.1.3 productS OFFERED
  4. 11.1.4 KEY DEVELOPMENTS
  5. 11.1.5 KEY STRATEGIES
2. 11.2 JOHNSON & JOHNSON INC.
  1. 11.2.1 COMPANY OVERVIEW
  2. 11.2.2 FINANCIAL OVERVIEW
  3. 11.2.3 products OFFERed
  4. 11.2.4 KEY DEVELOPMENTS
  5. 11.2.5 KEY STRATEGIES
3. 11.3 SANOFI
  1. 11.3.1 COMPANY OVERVIEW
  2. 11.3.2 FINANCIAL OVERVIEW
  3. 11.3.3 PRODUCTS OFFERED
  4. 11.3.4 KEY DEVELOPMENTS
  5. 11.3.5 KEY STRATEGIES
4. 11.4 BECTON, DICKINSON AND COMPANY
  1. 11.4.1 COMPANY OVERVIEW
  2. 11.4.2 FINANCIAL OVERVIEW
  3. 11.4.3 PRODUCTS/SERVICES OFFERed
  4. 11.4.4 KEY DEVELOPMENTS
  5. 11.4.5 SWOT ANALYSIS
  6. 11.4.6 KEY STRATEGIES
5. 11.5 MEDTRONIC
  1. 11.5.1 COMPANY OVERVIEW
  2. 11.5.2 FINANCIAL OVERVIEW
  3. 11.5.3 Products/services OFFERED
  4. 11.5.4 KEY DEVELOPMENTS
  5. 11.5.5 SWOT ANALYSIS
  6. 11.5.6 KEY STRATEGIES
6. 11.6 STRYKER
  1. 11.6.1 COMPANY OVERVIEW
  2. 11.6.2 FINANCIAL OVERVIEW
  3. 11.6.3 products OFFERED
  4. 11.6.4 KEY DEVELOPMENTS
  5. 11.6.5 SWOT ANALYSIS
  6. 11.6.6 KEY STRATEGIES
7. 11.7 SMITH+NEPHEW
  1. 11.7.1 COMPANY OVERVIEW
  2. 11.7.2 FINANCIAL OVERVIEW
  3. 11.7.3 Products OFFERed
  4. 11.7.4 KEY DEVELOPMENTS
  5. 11.7.5 SWOT ANALYSIS
  6. 11.7.6 KEY STRATEGIES
8. 11.8 BAXTER
  1. 11.8.1 COMPANY OVERVIEW
  2. 11.8.2 FINANCIAL OVERVIEW
  3. 11.8.3 products OFFERed
  4. 11.8.4 KEY DEVELOPMENTS
  5. 11.8.5 KEY STRATEGIES
9. 11.9 ZIMMER BIOMET
  1. 11.9.1 COMPANY OVERVIEW
  2. 11.9.2 FINANCIAL OVERVIEW
  3. 11.9.3 products OFFERed
  4. 11.9.4 KEY DEVELOPMENTS
  5. 11.9.5 KEY STRATEGIES
10. 11.10 B. BRAUN SE
  1. 11.10.1 COMPANY OVERVIEW
  2. 11.10.2 FINANCIAL OVERVIEW
  3. 11.10.3 products OFFERed
  4. 11.10.4 KEY DEVELOPMENTS
  5. 11.10.5 SWOT ANALYSIS
  6. 11.10.6 KEY STRATEGIES
12 DATA CITATIONS
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 GLOBAL BIOSURGERY MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION)
TABLE 3 GLOBAL BIOSURGERY MARKET, FOR BONE-GRAFT SUBSTITUTES, 2019–2035 (USD MILLION)
TABLE 4 GLOBAL BIOSURGERY MARKET, FOR HEMOSTATIC AGENTS, 2019–2035 (USD MILLION)
TABLE 5 GLOBAL BIOSURGERY MARKET, FOR SOFT-TISSUE ATTACHMENTS, 2019–2035 (USD MILLION)
TABLE 6 GLOBAL BIOSURGERY MARKET, FOR SURGICAL SEALANTS AND ADHESIVES, 2019–2035 (USD MILLION)
TABLE 7 GLOBAL BIOSURGERY MARKET, FOR ADHESION BARRIERS, 2019–2035 (USD MILLION)
TABLE 8 GLOBAL BIOSURGERY MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 9 GLOBAL BIOSURGERY MARKET, BY END USE, 2019–2035 (USD MILLION)
TABLE 10 GLOBAL BIOSURGERY MARKET, BY REGION, 2019-2035 (USD MILLION)
TABLE 11 NORTH AMERICA BIOSURGERY MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
TABLE 12 NORTH AMERICA: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
TABLE 13 NORTH AMERICA: BIOSURGERY MARKET, FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2019-2035 (USD MILLION)
TABLE 14 NORTH AMERICA: BIOSURGERY MARKET, FOR HEMOSTATIC AGENTS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 15 NORTH AMERICA: BIOSURGERY MARKET, FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 16 NORTH AMERICA: BIOSURGERY MARKET, FOR SURGICAL SEALANTS AND ADHESIVES, BY TYPE, 2019-2035 (USD MILLION)
TABLE 17 NORTH AMERICA: BIOSURGERY MARKET, FOR ADHESION BARRIERS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 18 NORTH AMERICA: BIOSURGERY MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
TABLE 19 NORTH AMERICA: BIOSURGERY MARKET, BY END USER, 2019-2035 (USD MILLION)
TABLE 20 US: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
TABLE 21 US: BIOSURGERY MARKET, FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2019-2035 (USD MILLION)
TABLE 22 US: BIOSURGERY MARKET, FOR HEMOSTATIC AGENTS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 23 US: BIOSURGERY MARKET, FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 24 US: BIOSURGERY MARKET, FOR SURGICAL SEALANTS AND ADHESIVES, BY TYPE, 2019-2035 (USD MILLION)
TABLE 25 US: BIOSURGERY MARKET, FOR ADHESION BARRIERS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 26 US: BIOSURGERY MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
TABLE 27 US: BIOSURGERY MARKET, BY END USER, 2019-2035 (USD MILLION)
TABLE 28 CANADA: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
TABLE 29 CANADA: BIOSURGERY MARKET, FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2019-2035 (USD MILLION)
TABLE 30 CANADA: BIOSURGERY MARKET, FOR HEMOSTATIC AGENTS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 31 CANADA: BIOSURGERY MARKET, FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 32 CANADA: BIOSURGERY MARKET, FOR SURGICAL SEALANTS AND ADHESIVES, BY TYPE, 2019-2035 (USD MILLION)
TABLE 33 CANADA: BIOSURGERY MARKET, FOR ADHESION BARRIERS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 34 CANADA: BIOSURGERY MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
TABLE 35 CANADA: BIOSURGERY MARKET, BY END USER, 2019-2035 (USD MILLION)
TABLE 36 EUROPE BIOSURGERY MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
TABLE 37 EUROPE: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
TABLE 38 EUROPE: BIOSURGERY MARKET, FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2019-2035 (USD MILLION)
TABLE 39 EUROPE: BIOSURGERY MARKET, FOR HEMOSTATIC AGENTS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 40 EUROPE: BIOSURGERY MARKET, FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 41 EUROPE: BIOSURGERY MARKET, FOR SURGICAL SEALANTS AND ADHESIVES, BY TYPE, 2019-2035 (USD MILLION)
TABLE 42 EUROPE: BIOSURGERY MARKET, FOR ADHESION BARRIERS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 43 EUROPE: BIOSURGERY MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
TABLE 44 EUROPE: BIOSURGERY MARKET, BY END USER, 2019-2035 (USD MILLION)
TABLE 45 GERMANY: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
TABLE 46 GERMANY: BIOSURGERY MARKET, FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2019-2035 (USD MILLION)
TABLE 47 GERMANY: BIOSURGERY MARKET, FOR HEMOSTATIC AGENTS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 48 GERMANY: BIOSURGERY MARKET, FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 49 GERMANY: BIOSURGERY MARKET, FOR SURGICAL SEALANTS AND ADHESIVES, BY TYPE, 2019-2035 (USD MILLION)
TABLE 50 GERMANY: BIOSURGERY MARKET, FOR ADHESION BARRIERS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 51 GERMANY: BIOSURGERY MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
TABLE 52 GERMANY: BIOSURGERY MARKET, BY END USER, 2019-2035 (USD MILLION)
TABLE 53 UK: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
TABLE 54 UK: BIOSURGERY MARKET, FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2019-2035 (USD MILLION)
TABLE 55 UK: BIOSURGERY MARKET, FOR HEMOSTATIC AGENTS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 56 UK: BIOSURGERY MARKET, FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 57 UK: BIOSURGERY MARKET, FOR SURGICAL SEALANTS AND ADHESIVES, BY TYPE, 2019-2035 (USD MILLION)
TABLE 58 UK: BIOSURGERY MARKET, FOR ADHESION BARRIERS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 59 UK: BIOSURGERY MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
TABLE 60 UK: BIOSURGERY MARKET, BY END USER, 2019-2035 (USD MILLION)
TABLE 61 FRANCE: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
TABLE 62 FRANCE: BIOSURGERY MARKET, FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2019-2035 (USD MILLION)
TABLE 63 FRANCE: BIOSURGERY MARKET, FOR HEMOSTATIC AGENTS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 64 FRANCE: BIOSURGERY MARKET, FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 65 FRANCE: BIOSURGERY MARKET, FOR SURGICAL SEALANTS AND ADHESIVES, BY TYPE, 2019-2035 (USD MILLION)
TABLE 66 FRANCE: BIOSURGERY MARKET, FOR ADHESION BARRIERS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 67 FRANCE: BIOSURGERY MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
TABLE 68 FRANCE: BIOSURGERY MARKET, BY END USER, 2019-2035 (USD MILLION)
TABLE 69 RUSSIA: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
TABLE 70 RUSSIA: BIOSURGERY MARKET, FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2019-2035 (USD MILLION)
TABLE 71 RUSSIA: BIOSURGERY MARKET, FOR HEMOSTATIC AGENTS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 72 RUSSIA: BIOSURGERY MARKET, FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 73 RUSSIA: BIOSURGERY MARKET, FOR SURGICAL SEALANTS AND ADHESIVES, BY TYPE, 2019-2035 (USD MILLION)
TABLE 74 RUSSIA: BIOSURGERY MARKET, FOR ADHESION BARRIERS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 75 RUSSIA: BIOSURGERY MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
TABLE 76 RUSSIA: BIOSURGERY MARKET, BY END USER, 2019-2035 (USD MILLION)
TABLE 77 ITALY: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
TABLE 78 ITALY: BIOSURGERY MARKET, FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2019-2035 (USD MILLION)
TABLE 79 ITALY: BIOSURGERY MARKET, FOR HEMOSTATIC AGENTS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 80 ITALY: BIOSURGERY MARKET, FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 81 ITALY: BIOSURGERY MARKET, FOR SURGICAL SEALANTS AND ADHESIVES, BY TYPE, 2019-2035 (USD MILLION)
TABLE 82 ITALY: BIOSURGERY MARKET, FOR ADHESION BARRIERS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 83 ITALY: BIOSURGERY MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
TABLE 84 ITALY: BIOSURGERY MARKET, BY END USER, 2019-2035 (USD MILLION)
TABLE 85 SPAIN: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
TABLE 86 SPAIN: BIOSURGERY MARKET, FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2019-2035 (USD MILLION)
TABLE 87 SPAIN: BIOSURGERY MARKET, FOR HEMOSTATIC AGENTS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 88 SPAIN: BIOSURGERY MARKET, FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 89 SPAIN: BIOSURGERY MARKET, FOR SURGICAL SEALANTS AND ADHESIVES, BY TYPE, 2019-2035 (USD MILLION)
TABLE 90 SPAIN: BIOSURGERY MARKET, FOR ADHESION BARRIERS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 91 SPAIN: BIOSURGERY MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
TABLE 92 SPAIN: BIOSURGERY MARKET, BY END USER, 2019-2035 (USD MILLION)
TABLE 93 REST OF EUROPE: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
TABLE 94 REST OF EUROPE: BIOSURGERY MARKET, FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2019-2035 (USD MILLION)
TABLE 95 REST OF EUROPE: BIOSURGERY MARKET, FOR HEMOSTATIC AGENTS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 96 REST OF EUROPE: BIOSURGERY MARKET, FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 97 REST OF EUROPE: BIOSURGERY MARKET, FOR SURGICAL SEALANTS AND ADHESIVES, BY TYPE, 2019-2035 (USD MILLION)
TABLE 98 REST OF EUROPE: BIOSURGERY MARKET, FOR ADHESION BARRIERS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 99 REST OF EUROPE: BIOSURGERY MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
TABLE 100 REST OF EUROPE: BIOSURGERY MARKET, BY END USER, 2019-2035 (USD MILLION)
TABLE 101 ASIA-PACIFIC: BIOSURGERY MARKET, BY COUNTRY, 2019–2035 (USD MILLION)
TABLE 102 ASIA-PACIFIC: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION)
TABLE 103 ASIA-PACIFIC: BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2019–2035 (USD MILLION)
TABLE 104 ASIA-PACIFIC: BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2019–2035 (USD MILLION)
TABLE 105 ASIA-PACIFIC: BIOSURGERY MARKET, BY SOFT-TISSUE ATTACHMENTS,2019–2035 (USD MILLION)
TABLE 106 ASIA-PACIFIC: BIOSURGERY MARKET, BY SURGICAL SEALANTS AND ADHESIVES, 2019–2035 (USD MILLION)
TABLE 107 ASIA-PACIFIC: BIOSURGERY MARKET, BY ADHESION BARRIERS, 2019–2035 (USD MILLION)
TABLE 108 ASIA-PACIFIC: BIOSURGERY MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 109 ASIA-PACIFIC: BIOSURGERY MARKET, BY END USE, 2019–2035 (USD MILLION)
TABLE 110 CHINA: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION)
TABLE 111 CHINA: BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2019–2035 (USD MILLION)
TABLE 112 CHINA: BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2019–2035 (USD MILLION)
TABLE 113 CHINA: BIOSURGERY MARKET, BY SOFT-TISSUE ATTACHMENTS,2019–2035 (USD MILLION)
TABLE 114 CHINA: BIOSURGERY MARKET, BY SURGICAL SEALANTS AND ADHESIVES, 2019–2035 (USD MILLION)
TABLE 115 CHINA: BIOSURGERY MARKET, BY ADHESION BARRIERS, 2019–2035 (USD MILLION)
TABLE 116 CHINA: BIOSURGERY MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 117 CHINA: BIOSURGERY MARKET, BY END USE, 2019–2035 (USD MILLION)
TABLE 118 INDIA: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION)
TABLE 119 INDIA: BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2019–2035 (USD MILLION)
TABLE 120 INDIA: BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2019–2035 (USD MILLION)
TABLE 121 INDIA: BIOSURGERY MARKET, BY SOFT-TISSUE ATTACHMENTS,2019–2035 (USD MILLION)
TABLE 122 INDIA: BIOSURGERY MARKET, BY SURGICAL SEALANTS AND ADHESIVES, 2019–2035 (USD MILLION)
TABLE 123 INDIA: BIOSURGERY MARKET, BY ADHESION BARRIERS, 2019–2035 (USD MILLION)
TABLE 124 INDIA: BIOSURGERY MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 125 INDIA: BIOSURGERY MARKET, BY END USE, 2019–2035 (USD MILLION)
TABLE 126 JAPAN: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION)
TABLE 127 JAPAN: BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2019–2035 (USD MILLION)
TABLE 128 JAPAN: BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2019–2035 (USD MILLION)
TABLE 129 JAPAN: BIOSURGERY MARKET, BY SOFT-TISSUE ATTACHMENTS,2019–2035 (USD MILLION)
TABLE 130 JAPAN: BIOSURGERY MARKET, BY SURGICAL SEALANTS AND ADHESIVES, 2019–2035 (USD MILLION)
TABLE 131 JAPAN: BIOSURGERY MARKET, BY ADHESION BARRIERS, 2019–2035 (USD MILLION)
TABLE 132 JAPAN: BIOSURGERY MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 133 JAPAN: BIOSURGERY MARKET, BY END USE, 2019–2035 (USD MILLION)
TABLE 134 SOUTH KOREA: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION)
TABLE 135 SOUTH KOREA: BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2019–2035 (USD MILLION)
TABLE 136 SOUTH KOREA: BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2019–2035 (USD MILLION)
TABLE 137 SOUTH KOREA: BIOSURGERY MARKET, BY SOFT-TISSUE ATTACHMENTS,2019–2035 (USD MILLION)
TABLE 138 SOUTH KOREA: BIOSURGERY MARKET, BY SURGICAL SEALANTS AND ADHESIVES, 2019–2035 (USD MILLION)
TABLE 139 SOUTH KOREA: BIOSURGERY MARKET, BY ADHESION BARRIERS, 2019–2035 (USD MILLION)
TABLE 140 SOUTH KOREA: BIOSURGERY MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 141 SOUTH KOREA: BIOSURGERY MARKET, BY END USE, 2019–2035 (USD MILLION)
TABLE 142 MALAYSIA: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION)
TABLE 143 MALAYSIA: BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2019–2035 (USD MILLION)
TABLE 144 MALAYSIA: BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2019–2035 (USD MILLION)
TABLE 145 MALAYSIA: BIOSURGERY MARKET, BY SOFT-TISSUE ATTACHMENTS,2019–2035 (USD MILLION)
TABLE 146 MALAYSIA: BIOSURGERY MARKET, BY SURGICAL SEALANTS AND ADHESIVES, 2019–2035 (USD MILLION)
TABLE 147 MALAYSIA: BIOSURGERY MARKET, BY ADHESION BARRIERS, 2019–2035 (USD MILLION)
TABLE 148 MALAYSIA: BIOSURGERY MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 149 MALAYSIA: BIOSURGERY MARKET, BY END USE, 2019–2035 (USD MILLION)
TABLE 150 THAILAND: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION)
TABLE 151 THAILAND: BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2019–2035 (USD MILLION)
TABLE 152 THAILAND: BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2019–2035 (USD MILLION)
TABLE 153 THAILAND: BIOSURGERY MARKET, BY SOFT-TISSUE ATTACHMENTS,2019–2035 (USD MILLION)
TABLE 154 THAILAND: BIOSURGERY MARKET, BY SURGICAL SEALANTS AND ADHESIVES, 2019–2035 (USD MILLION)
TABLE 155 THAILAND: BIOSURGERY MARKET, BY ADHESION BARRIERS, 2019–2035 (USD MILLION)
TABLE 156 THAILAND: BIOSURGERY MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 157 THAILAND: BIOSURGERY MARKET, BY END USE, 2019–2035 (USD MILLION)
TABLE 158 INDONESIA: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION)
TABLE 159 INDONESIA: BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2019–2035 (USD MILLION)
TABLE 160 INDONESIA: BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2019–2035 (USD MILLION)
TABLE 161 INDONESIA: BIOSURGERY MARKET, BY SOFT-TISSUE ATTACHMENTS,2019–2035 (USD MILLION)
TABLE 162 INDONESIA: BIOSURGERY MARKET, BY SURGICAL SEALANTS AND ADHESIVES, 2019–2035 (USD MILLION)
TABLE 163 INDONESIA: BIOSURGERY MARKET, BY ADHESION BARRIERS, 2019–2035 (USD MILLION)
TABLE 164 INDONESIA: BIOSURGERY MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 165 INDONESIA: BIOSURGERY MARKET, BY END USE, 2019–2035 (USD MILLION)
TABLE 166 REST OF ASIA PACIFIC: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION)
TABLE 167 REST OF ASIA PACIFIC: BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2019–2035 (USD MILLION)
TABLE 168 REST OF ASIA PACIFIC: BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2019–2035 (USD MILLION)
TABLE 169 REST OF ASIA PACIFIC: BIOSURGERY MARKET, BY SOFT-TISSUE ATTACHMENTS,2019–2035 (USD MILLION)
TABLE 170 REST OF ASIA PACIFIC: BIOSURGERY MARKET, BY SURGICAL SEALANTS AND ADHESIVES, 2019–2035 (USD MILLION)
TABLE 171 REST OF ASIA PACIFIC: BIOSURGERY MARKET, BY ADHESION BARRIERS, 2019–2035 (USD MILLION)
TABLE 172 REST OF ASIA PACIFIC: BIOSURGERY MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 173 REST OF ASIA PACIFIC: BIOSURGERY MARKET, BY END USE, 2019–2035 (USD MILLION)
TABLE 174 LATIN AMERICA: BIOSURGERY MARKET, BY COUNTRY, 2019–2035 (USD MILLION)
TABLE 175 LATIN AMERICA: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION)
TABLE 176 LATIN AMERICA: BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2019–2035 (USD MILLION)
TABLE 177 LATIN AMERICA: BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2019–2035 (USD MILLION)
TABLE 178 LATIN AMERICA: BIOSURGERY MARKET, BY SOFT-TISSUE ATTACHMENTS,2019–2035 (USD MILLION)
TABLE 179 LATIN AMERICA: BIOSURGERY MARKET, BY SURGICAL SEALANTS AND ADHESIVES, 2019–2035 (USD MILLION)
TABLE 180 LATIN AMERICA: BIOSURGERY MARKET, BY ADHESION BARRIERS, 2019–2035 (USD MILLION)
TABLE 181 LATIN AMERICA: BIOSURGERY MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 182 LATIN AMERICA: BIOSURGERY MARKET, BY END USE, 2019–2035 (USD MILLION)
TABLE 183 BRAZIL: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION)
TABLE 184 BRAZIL: BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2019–2035 (USD MILLION)
TABLE 185 BRAZIL: BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2019–2035 (USD MILLION)
TABLE 186 BRAZIL: BIOSURGERY MARKET, BY SOFT-TISSUE ATTACHMENTS,2019–2035 (USD MILLION)
TABLE 187 BRAZIL: BIOSURGERY MARKET, BY SURGICAL SEALANTS AND ADHESIVES, 2019–2035 (USD MILLION)
TABLE 188 BRAZIL: BIOSURGERY MARKET, BY ADHESION BARRIERS, 2019–2035 (USD MILLION)
TABLE 189 BRAZIL: BIOSURGERY MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 190 BRAZIL: BIOSURGERY MARKET, BY END USE, 2019–2035 (USD MILLION)
TABLE 191 MEXICO: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION)
TABLE 192 MEXICO: BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2019–2035 (USD MILLION)
TABLE 193 MEXICO: BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2019–2035 (USD MILLION)
TABLE 194 MEXICO: BIOSURGERY MARKET, BY SOFT-TISSUE ATTACHMENTS,2019–2035 (USD MILLION)
TABLE 195 MEXICO: BIOSURGERY MARKET, BY SURGICAL SEALANTS AND ADHESIVES, 2019–2035 (USD MILLION)
TABLE 196 MEXICO: BIOSURGERY MARKET, BY ADHESION BARRIERS, 2019–2035 (USD MILLION)
TABLE 197 MEXICO: BIOSURGERY MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 198 MEXICO: BIOSURGERY MARKET, BY END USE, 2019–2035 (USD MILLION)
TABLE 199 ARGENTINA: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION)
TABLE 200 ARGENTINA: BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2019–2035 (USD MILLION)
TABLE 201 ARGENTINA: BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2019–2035 (USD MILLION)
TABLE 202 ARGENTINA: BIOSURGERY MARKET, BY SOFT-TISSUE ATTACHMENTS,2019–2035 (USD MILLION)
TABLE 203 ARGENTINA: BIOSURGERY MARKET, BY SURGICAL SEALANTS AND ADHESIVES, 2019–2035 (USD MILLION)
TABLE 204 ARGENTINA: BIOSURGERY MARKET, BY ADHESION BARRIERS, 2019–2035 (USD MILLION)
TABLE 205 ARGENTINA: BIOSURGERY MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 206 ARGENTINA: BIOSURGERY MARKET, BY END USE, 2019–2035 (USD MILLION)
TABLE 207 REST OF LATIN AMERICA: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION)
TABLE 208 REST OF LATIN AMERICA: BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2019–2035 (USD MILLION)
TABLE 209 REST OF LATIN AMERICA: BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2019–2035 (USD MILLION)
TABLE 210 REST OF LATIN AMERICA: BIOSURGERY MARKET, BY SOFT-TISSUE ATTACHMENTS,2019–2035 (USD MILLION)
TABLE 211 REST OF LATIN AMERICA: BIOSURGERY MARKET, BY SURGICAL SEALANTS AND ADHESIVES, 2019–2035 (USD MILLION)
TABLE 212 REST OF LATIN AMERICA: BIOSURGERY MARKET, BY ADHESION BARRIERS, 2019–2035 (USD MILLION)
TABLE 213 REST OF LATIN AMERICA: BIOSURGERY MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 214 REST OF LATIN AMERICA: BIOSURGERY MARKET, BY END USE, 2019–2035 (USD MILLION)
TABLE 215 MIDDLE EAST & AFRICA: BIOSURGERY MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
TABLE 216 MIDDLE EAST & AFRICA: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION)
TABLE 217 MIDDLE EAST & AFRICA: BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2019–2035 (USD MILLION)
TABLE 218 MIDDLE EAST & AFRICA: BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2019–2035 (USD MILLION)
TABLE 219 MIDDLE EAST & AFRICA: BIOSURGERY MARKET, BY SOFT-TISSUE ATTACHMENTS, 2019–2035 (USD MILLION)
TABLE 220 MIDDLE EAST & AFRICA: BIOSURGERY MARKET, BY SURGICAL SEALANTS AND ADHESIVES, 2019–2035 (USD MILLION)
TABLE 221 MIDDLE EAST & AFRICA: BIOSURGERY MARKET, BY ADHESION BARRIERS, 2019–2035 (USD MILLION)
TABLE 222 MIDDLE EAST & AFRICA: BIOSURGERY MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 223 MIDDLE EAST & AFRICA: BIOSURGERY MARKET, BY END USE, 2019–2035 (USD MILLION)
TABLE 224 GCC COUNTRIES: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION)
TABLE 225 GCC COUNTRIES: BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2019–2035 (USD MILLION)
TABLE 226 GCC COUNTRIES: BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2019–2035 (USD MILLION)
TABLE 227 GCC COUNTRIES: BIOSURGERY MARKET, BY SOFT-TISSUE ATTACHMENTS, 2019–2035 (USD MILLION)
TABLE 228 GCC COUNTRIES: BIOSURGERY MARKET, BY SURGICAL SEALANTS AND ADHESIVES, 2019–2035 (USD MILLION)
TABLE 229 GCC COUNTRIES: BIOSURGERY MARKET, BY ADHESION BARRIERS, 2019–2035 (USD MILLION)
TABLE 230 GCC COUNTRIES: BIOSURGERY MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 231 GCC COUNTRIES: BIOSURGERY MARKET, BY END USE, 2019–2035 (USD MILLION)
TABLE 232 SOUTH AFRICA: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION)
TABLE 233 SOUTH AFRICA: BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2019–2035 (USD MILLION)
TABLE 234 SOUTH AFRICA: BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2019–2035 (USD MILLION)
TABLE 235 SOUTH AFRICA: BIOSURGERY MARKET, BY SOFT-TISSUE ATTACHMENTS, 2019–2035 (USD MILLION)
TABLE 236 SOUTH AFRICA: BIOSURGERY MARKET, BY SURGICAL SEALANTS AND ADHESIVES, 2019–2035 (USD MILLION)
TABLE 237 SOUTH AFRICA: BIOSURGERY MARKET, BY ADHESION BARRIERS, 2019–2035 (USD MILLION)
TABLE 238 SOUTH AFRICA: BIOSURGERY MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 239 SOUTH AFRICA: BIOSURGERY MARKET, BY END USE, 2019–2035 (USD MILLION)
TABLE 240 REST OF MEA: BIOSURGERY MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION)
TABLE 241 REST OF MEA: BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2019–2035 (USD MILLION)
TABLE 242 REST OF MEA: BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2019–2035 (USD MILLION)
TABLE 243 REST OF MEA: BIOSURGERY MARKET, BY SOFT-TISSUE ATTACHMENTS, 2019–2035 (USD MILLION)
TABLE 244 REST OF MEA: BIOSURGERY MARKET, BY SURGICAL SEALANTS AND ADHESIVES, 2019–2035 (USD MILLION)
TABLE 245 REST OF MEA: BIOSURGERY MARKET, BY ADHESION BARRIERS, 2019–2035 (USD MILLION)
TABLE 246 REST OF MEA: BIOSURGERY MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 247 REST OF MEA: BIOSURGERY MARKET, BY END USE, 2019–2035 (USD MILLION)
TABLE 248 PRODUCT LAUNCH
TABLE 249 PRODUCT DEVELOPMENT
TABLE 250 PARTNERSHIP
TABLE 251 ACQUISITION/ EXPANSION
TABLE 252 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT OFFERED
TABLE 253 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY DEVELOPMENTS
TABLE 254 JOHNSON & JOHNSON INC.: PRODUCTS OFFERED
TABLE 255 JOHNSON & JOHNSON INC.: KEY DEVELOPMENTS
TABLE 256 SANOFI: PRODUCTS OFFERED
TABLE 257 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
TABLE 258 BECTON, DICKINSON AND COMPANY: KEY DEVELOPMENTS
TABLE 259 MEDTRONIC: PRODUCTS OFFERED
TABLE 260 MEDTRONIC: KEY DEVELOPMENTS
TABLE 261 STRYKER: PRODUCTS OFFERED
TABLE 262 STRYKER: KEY DEVELOPMENTS
TABLE 263 SMITH+NEPHEW: PRODUCTS OFFERED
TABLE 264 STRYKER: KEY DEVELOPMENTS
TABLE 265 BAXTER: PRODUCTS OFFERED
TABLE 266 BAXTER: KEY DEVELOPMENTS
TABLE 267 ZIMMER BIOMET: PRODUCTS OFFERED
TABLE 268 ZIMMER BIOMET: KEY DEVELOPMENTS
TABLE 269 B. BRAUN SE: PRODUCTS OFFERED
LIST OF FIGURES
FIGURE 1 GLOBAL BIOSURGERY MARKET: STRUCTURE
FIGURE 2 GLOBAL BIOSURGERY MARKET: MARKET GROWTH AFFECTING FACTOR ANALYSIS (2019-2035)
FIGURE 3 GLOBAL POPULATION AGES 65 AND ABOVE (IN MILLIONS)
FIGURE 4 GLOBAL BIOSURGERY MARKET DRIVER: IMPACT ANALYSIS
FIGURE 5 GLOBAL BIOSURGERY MARKET RESTRAINT: IMPACT ANALYSIS
FIGURE 6 GLOBAL BIOSURGERY MARKET, BY PRODUCT TYPE, SEGMENT ATTRACTIVENESS ANALYSIS
FIGURE 7 GLOBAL BIOSURGERY MARKET, BY PRODUCT TYPE, 2024 & 2035 (USD MILLION)
FIGURE 8 GLOBAL BIOSURGERY MARKET SHARE (%), BY PRODUCT TYPE, 2024
FIGURE 9 GLOBAL BIOSURGERY MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2024 & 2035 (USD MILLION)
FIGURE 10 GLOBAL BIOSURGERY MARKET, BY APPLICATION, 2024 & 2035 (USD MILLION)
FIGURE 11 GLOBAL BIOSURGERY MARKET SHARE (%), BY APPLICATION, 2024
FIGURE 12 GLOBAL BIOSURGERY MARKET, END USER SEGMENT ATTRACTIVENESS, 2024 & 2035 (USD MILLION)
FIGURE 13 GLOBAL BIOSURGERY MARKET, BY END USE, 2024 & 2035 (USD MILLION)
FIGURE 14 GLOBAL BIOSURGERY MARKET SHARE (%), BY END USE, 2024
FIGURE 15 GLOBAL BIOSURGERY MARKET, BY REGION, 2024 & 2035 (USD MILLION)
FIGURE 16 GLOBAL BIOSURGERY MARKET SHARE (%), BY REGION, 2024
FIGURE 17 NORTH AMERICA MARKET ANALYSIS: BIOSURGERY MARKET, 2019-2035 (USD MILLION)
FIGURE 18 NORTH AMERICA BIOSURGERY MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION)
FIGURE 19 NORTH AMERICA BIOSURGERY MARKET SHARE (%), BY COUNTRY, 2024
FIGURE 20 EUROPE MARKET ANALYSIS: BIOSURGERY MARKET, 2019-2035 (USD MILLION)
FIGURE 21 EUROPE BIOSURGERY MARKET, BY REGION, 2024 & 2035 (USD MILLION)
FIGURE 22 EUROPE BIOSURGERY MARKET SHARE (%), BY COUNTRY, 2024
FIGURE 23 ASIA-PACIFIC MARKET ANALYSIS: BIOSURGERY MARKET, 2019-2035 (USD MILLION)
FIGURE 24 ASIA-PACIFIC: BIOSURGERY MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION)
FIGURE 25 ASIA-PACIFIC: BIOSURGERY MARKET SHARE, BY COUNTRY, 2024 (%)
FIGURE 26 LATIN AMERICA MARKET ANALYSIS: BIOSURGERY MARKET, 2019-2035 (USD MILLION)
FIGURE 27 LATIN AMERICA: BIOSURGERY MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION)
FIGURE 28 LATIN AMERICA: BIOSURGERY MARKET SHARE, BY COUNTRY, 2024 (%)
FIGURE 29 MIDDLE EAST AND AFRICA MARKET SWOT ANALYSIS: BIOSURGERY MARKET
FIGURE 30 MIDDLE EAST & AFRICA: BIOSURGERY MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION)
FIGURE 31 MIDDLE EAST & AFRICA: BIOSURGERY MARKET SHARE (%), BY COUNTRY, 2024
FIGURE 32 GLOBAL BIOSURGERY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2024
FIGURE 33 COMPETITOR DASHBOARD: GLOBAL BIOSURGERY MARKET
FIGURE 34 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 JOHNSON & JOHNSON INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 SANOFI: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 37 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 38 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS
FIGURE 39 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 40 MEDTRONIC: SWOT ANALYSIS
FIGURE 41 STRYKER: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 42 STRYKER: SWOT ANALYSIS
FIGURE 43 SMITH+NEPHEW: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 44 SMITH+NEPHEW: SWOT ANALYSIS
FIGURE 45 BAXTER: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 46 ZIMMER BIOMET: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 47 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 48 B. BRAUN SE: SWOT ANALYSIS

Certified Researchers

Customize Report

Biosurgery Market Segmentation

Global Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
Global Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
Global Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users

Biosurgery Market Regional Outlook (USD Million, 2019-2035)

North America Outlook (USD Million, 2019-2035)
North America Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
North America Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
North America Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
- US Outlook (USD Million, 2019-2035)
US Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
US Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
US Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
- Canada Outlook (USD Million, 2019-2035)
Canada Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
Canada Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
Canada Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
Europe Outlook (USD Million, 2019-2035)
Europe Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
Europe Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
Europe Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
- Germany Outlook (USD Million, 2019-2035)
Germany Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
Germany Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
Germany Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
- UK Outlook (USD Million, 2019-2035)
UK Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
UK Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
UK Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
- France Outlook (USD Million, 2019-2035)
France Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
France Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
France Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
- Russia Outlook (USD Million, 2019-2035)
Russia Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
Russia Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
Russia Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
- Italy Outlook (USD Million, 2019-2035)
Global Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
Global Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
Global Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
- Spain Outlook (USD Million, 2019-2035)
Global Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
Global Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
Global Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
- Rest Of Europe Outlook (USD Million, 2019-2035)
Global Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
Global Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
Global Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
Asia-Pacific Outlook (USD Million, 2019-2035)
Global Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
Global Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
Global Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
- China Outlook (USD Million, 2019-2035)
Global Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
Global Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
Global Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
- India Outlook (USD Million, 2019-2035)
Global Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
Global Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
Global Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
- Japan Outlook (USD Million, 2019-2035)
Global Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
Global Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
Global Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
- South Korea Outlook (USD Million, 2019-2035)
Global Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
Global Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
Global Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
- Rest of Asia-Pacific Outlook (USD Million, 2019-2035)
Global Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
Global Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
Global Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
South America Outlook (USD Million, 2019-2035)
Global Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
Global Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
Global Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
- Brazil Outlook (USD Million, 2019-2035)
Global Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
Global Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
Global Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
- Mexico Outlook (USD Million, 2019-2035)
Mexico Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
Mexico Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
Mexico Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
- Argentina Outlook (USD Million, 2019-2035)
Argentina Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
Argentina Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
Argentina Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
- Rest of South America Outlook (USD Million, 2019-2035)
Rest of South America Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
Rest of South America Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
Rest of South America Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
Middle East & Africa Outlook (USD Million, 2019-2035)
Middle East & Africa Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
Middle East & Africa Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
Middle East & Africa Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
- GCC Countries Outlook (USD Million, 2019-2035)
GCC Countries Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
GCC Countries Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
GCC Countries Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
- South Africa Outlook (USD Million, 2019-2035)
South Africa Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
South Africa Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
South Africa Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users
- Rest of Middle East & Africa Outlook (USD Million, 2019-2035)
Rest of Middle East & Africa Biosurgery Market by Product type Outlook (USD Million, 2019-2035)
Bone-graft substitutes
Hemostatic agents
Soft-tissue attachments
Surgical sealants and adhesives
Adhesion barriers
Rest of Middle East & Africa Biosurgery Market by Application Outlook (USD Million, 2019-2035)
Neurological surgery
General surgery
Cardiovascular surgery
Orthopedic surgery
Thoracic surgery
Gynecology surgery
Urology surgery
Other applications
Rest of Middle East & Africa Biosurgery Market by End Use Outlook (USD Million, 2019-2035)
Hospitals and clinics
Ambulatory surgical centers
Other end users

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓

Biosurgery Market

Biosurgery Market Segmentation

Biosurgery Market Regional Outlook (USD Million, 2019-2035)

Related Reports

Customer Stories

Aerospace & Defense

Compare Licence